Kekulé #204: mRNA-Impfstoffe bekommen Konkurrenz

from Kekulés Gesundheits-Kompass von MDR AKTUELL

Für den Protein-Impfstoff von Novavax liegt die Zulassungsstudie vor – und die Daten sehen gut aus. Außerdem: Wie sollen wir damit umgehen, dass die Stiko nun generell bei Astrazeneca eine mRNA-Zweitimpfung empfiehlt?

Episode metadata supplied by the publisher feed · Published Jul 8, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Kekulé #204: mRNA-Impfstoffe bekommen Konkurrenz

0:00 1:02:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Kekulés Gesundheits-Kompass von MDR AKTUELL?

This episode is 1 hour and 2 minutes long.

When was this Kekulés Gesundheits-Kompass von MDR AKTUELL episode published?

This episode was published on July 8, 2021.

Can I download this Kekulés Gesundheits-Kompass von MDR AKTUELL episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!